For pharmaceutical and medtech brands, this sends a clear message: Brands supported by robust local and global Real-World Evidence are better positioned to earn physician trust, accelerate adoption, and demonstrate value beyond efficacy endpoints
How do you prevent muscle loss on GLP-1 medications
But if I wait and the reason I wrote this book, if youre going to wait for the day that our food environment changes, I dont have time
K.ParkE
Medical conditions that reduce response Several conditions can blunt semaglutide effectiveness regardless of whether it is compounded or brand-name: Hypothyroidism , especially untreated or undertreated, slows metabolism and counteracts weight loss Insulin resistance and type 2 diabetes can require higher doses for the same effect PCOS creates hormonal resistance to weight loss interventions Cushing syndrome and other cortisol disorders override appetite suppression mechanisms Certain medications , including some antidepressants, antipsychotics, corticosteroids, and beta-blockers, promote weight gain through independent pathways If you have any of these conditions, semaglutide may still work but could require higher doses or additional interventions